Skip to main content

Research Repository

Advanced Search

Long‐term follow‐up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors

Allsup, David John; Craig, Zoe; Cairns, David; Howard, Dena; Hockaday, Anna; Bloor, Adrian; Soe, Zarni; Pepper, Christopher; Gattei, Valter; Zucchetto, Antonella; Robbe, Pauline; Clifford, Ruth; Schuh, Anna; Munir, Tahla; Rawstron, Andrew; Hillmen, Peter

Authors

Zoe Craig

David Cairns

Dena Howard

Anna Hockaday

Adrian Bloor

Zarni Soe

Christopher Pepper

Valter Gattei

Antonella Zucchetto

Pauline Robbe

Ruth Clifford

Anna Schuh

Tahla Munir

Andrew Rawstron

Peter Hillmen



Citation

Allsup, D. J., Craig, Z., Cairns, D., Howard, D., Hockaday, A., Bloor, A., Soe, Z., Pepper, C., Gattei, V., Zucchetto, A., Robbe, P., Clifford, R., Schuh, A., Munir, T., Rawstron, A., & Hillmen, P. (in press). Long‐term follow‐up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors. American Journal of Hematology, https://doi.org/10.1002/ajh.26483

Journal Article Type Article
Acceptance Date Jan 31, 2022
Online Publication Date Feb 2, 2022
Deposit Date Feb 4, 2022
Publicly Available Date Feb 3, 2023
Journal American Journal of Hematology
Print ISSN 0361-8609
Electronic ISSN 1096-8652
Publisher Wiley
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1002/ajh.26483
Keywords Hematology
Public URL https://hull-repository.worktribe.com/output/3920905

Files

Accepted article (1.1 Mb)
PDF

Copyright Statement
©2022 The authors. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder





You might also like



Downloadable Citations